Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 5/20 | 0.63 |
| ▸ | ELANE | P08246 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2217463 | 0.77 | CD69 (1.00) | CD69ELANEKMT2APTGDR2ALOX15 | |
| SCHEMBL2184946 | 0.77 | CD69 (1.00) | CD69ELANEKMT2APTGDR2ALOX15 | |
| SCHEMBL19570312 | 0.77 | CD69 (1.00) | CD69ELANEKMT2AALOX15TSHR | |
| SCHEMBL16545618 | 0.76 | CD69 (0.56) | CD69ELANEKMT2APTGDR2ALOX15 | |
| SCHEMBL14931907 | 0.76 | MCL1 (0.45) | CD69ELANEKMT2APTGDR2HSD17B10 | |
| SCHEMBL3924075 | 0.72 | ALOX15 (0.54) | CD69KMT2APTGDR2ALOX15TSHR | |
| SCHEMBL29299544 | 0.72 | CD69 (0.86) | CD69ELANEKMT2APTGDR2ALOX15 | |
| SCHEMBL16545626 | 0.71 | CD69 (0.83) | CD69ELANEPTPN1SMN1; SMN2 | |
| SCHEMBL18538278 | 0.71 | CD69 (0.54) | CD69ELANEKMT2AKDM4E | |
| SCHEMBL18538316 | 0.71 | CD69 (0.54) | CD69ELANEKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150064455-A1 | MATERIALS COATED WITH CALIXARENES | UNIVERSITÉ PARIS CITÉ (FR) | 2015-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150064455-A1 | MATERIALS COATED WITH CALIXARENES | CALD1, CALU, CALR | CD69 672/4885ELANE 311/4885KMT2A 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.